PL1954251T3 - Kompozycja o wydłużonym uwalnianiu soli żelaza jako aktywnego składnika, sposób jej otrzymywania i jej zastosowanie - Google Patents

Kompozycja o wydłużonym uwalnianiu soli żelaza jako aktywnego składnika, sposób jej otrzymywania i jej zastosowanie

Info

Publication number: PL1954251T3
Authority: PL; Poland
Prior art keywords: slow; salt; preparation; active ingredient; same
Prior art date: 2005-12-01

Application number

PL06831163T

Other languages

English (en)

Inventor

Didier Berthoumieu

Pierre Dupinay

Philippe Trannoy

Original Assignee

Pf Medicament

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-01

Filing date

2006-11-23

Publication date

2012-08-31

2006-11-23 Application filed by Pf Medicament filed Critical Pf Medicament

2012-08-31 Publication of PL1954251T3 publication Critical patent/PL1954251T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL06831163T 2005-12-01 2006-11-23 Kompozycja o wydłużonym uwalnianiu soli żelaza jako aktywnego składnika, sposób jej otrzymywania i jej zastosowanie PL1954251T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0512189A FR2894143B1 (fr)	2005-12-01	2005-12-01	Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
EP06831163A EP1954251B1 (fr)	2005-12-01	2006-11-23	Composition a liberation prolongee de sel de fer en tant qu'actif, son procede de preparation et son utilisation
PCT/FR2006/002577 WO2007063200A1 (fr)	2005-12-01	2006-11-23	Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation

Publications (1)

Publication Number	Publication Date
PL1954251T3 true PL1954251T3 (pl)	2012-08-31

Family

ID=36968738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06831163T PL1954251T3 (pl)	2005-12-01	2006-11-23	Kompozycja o wydłużonym uwalnianiu soli żelaza jako aktywnego składnika, sposób jej otrzymywania i jej zastosowanie

Country Status (27)

Country	Link
US (1)	US8834923B2 (pl)
EP (1)	EP1954251B1 (pl)
JP (1)	JP5674275B2 (pl)
KR (1)	KR101332744B1 (pl)
CN (1)	CN101321520A (pl)
AR (1)	AR057212A1 (pl)
AT (1)	ATE548030T1 (pl)
AU (1)	AU2006319077B2 (pl)
BR (1)	BRPI0619774B1 (pl)
CA (1)	CA2632547C (pl)
DK (1)	DK1954251T3 (pl)
ES (1)	ES2383760T3 (pl)
FR (1)	FR2894143B1 (pl)
IL (1)	IL191758A (pl)
MA (1)	MA29770B1 (pl)
NO (1)	NO339720B1 (pl)
NZ (1)	NZ566783A (pl)
PL (1)	PL1954251T3 (pl)
PT (1)	PT1954251E (pl)
RS (1)	RS52308B (pl)
RU (1)	RU2414211C2 (pl)
SI (1)	SI1954251T1 (pl)
TN (1)	TNSN08152A1 (pl)
TW (1)	TWI374035B (pl)
UA (1)	UA93530C2 (pl)
WO (1)	WO2007063200A1 (pl)
ZA (1)	ZA200801896B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0613583D0 (en) *	2006-07-05	2006-08-16	Sericol Ltd	A printing ink
CN101912049A (zh) *	2010-07-27	2010-12-15	广州市正百饲料科技有限公司	包被微量元素预混料及其制备方法
CN103191078B (zh) *	2012-01-06	2018-01-09	常州善美药物研究开发中心有限公司	一种双膜多药层的高溶解度盐类药物控释片
NL2014348B1 (en)	2015-02-25	2016-10-13	Univ Delft Tech	Controlled release from particles encapsulated by molecular layer deposition.
RU2702690C2 (ru) *	2015-08-13	2019-10-09	БИОЛИНГУС АйПи ЛЛСи	Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые
RU2616264C1 (ru) *	2016-03-28	2017-04-13	Санкт-Петербургское Государственное бюджетное учреждение здравоохранения "Родильный дом N 10"	Способ профилактики железодефицитной анемии у несовершеннолетних беременных женщин
RU2623071C1 (ru) *	2016-09-29	2017-06-21	федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет"	Лечебно-профилактический хелатный железосодержащий препарат для сельскохозяйственных животных
CN106344534B (zh) *	2016-09-30	2019-07-19	广西科技大学	硫酸亚铁肠溶滴丸的制备方法
WO2019097400A1 (en) *	2017-11-14	2019-05-23	Greem Pharm S.R.L.	Oral administration form comprising an iron-copper mixture and its use as a food supplement
CN109999058A (zh) *	2019-05-22	2019-07-12	江阴天江药业有限公司	一种胶类中药的烊化方法和产品，以及由该产品制得的固体饮料及其制备方法
US20250319027A1 (en) *	2022-07-01	2025-10-16	Vitakey Inc.	Nutraceutical particles

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3622487A1 (de) *	1986-07-02	1988-01-14	Schering Ag	Arzneimittel mit verzoegerter wirkstoffabgabe
IE82916B1 (en) *	1990-11-02	2003-06-11	Elan Corp Plc	Formulations and their use in the treatment of neurological diseases
US5286493A (en) *	1992-01-27	1994-02-15	Euroceltique, S.A.	Stabilized controlled release formulations having acrylic polymer coating
US5478577A (en) *	1993-11-23	1995-12-26	Euroceltique, S.A.	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
DE4332394A1 (de) *	1993-09-23	1995-03-30	Falk Pharma Gmbh	Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
FR2792527B1 (fr) *	1999-04-22	2004-08-13	Ethypharm Lab Prod Ethiques	Microgranules de ketoprofene, procede de preparation et compositions pharmaceutiques
DE50008261D1 (de) *	1999-08-31	2004-11-18	Gruenenthal Gmbh	Retardierte darreichungsform enthaltend tramadolsaccharinat
PT1207866E (pt) *	1999-08-31	2005-02-28	Gruenenthal Gmbh	Forma de administracao retardada contendo sacarinato de tramadol
WO2001015665A1 (en) *	1999-09-02	2001-03-08	Nostrum Pharmaceuticals, Inc.	Controlled release oral dosage suitable for oral administration
WO2001045668A2 (en)	1999-12-20	2001-06-28	Schering Corporation	Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
DE10013029A1 (de) *	2000-03-17	2001-09-20	Roehm Gmbh	Mehrschichtige Arzneiform für die Colonfreigabe
EA200201044A1 (ru) *	2000-03-31	2003-04-24	Нюкомед Аустриа Гмбх	Фармацевтическая композиция с контролируемым высвобождением, содержащая мидодрин и/или десглимидодрин
AR030557A1 (es) *	2000-04-14	2003-08-27	Jagotec Ag	Una tableta en multicapa de liberacion controlada y metodo de tratamiento
KR100477874B1 (ko)	2001-04-10	2005-03-22	곽해수	지방산에스터를 이용한 수용성 철분 미세캡슐
EP1423092A2 (en) *	2001-09-05	2004-06-02	Vectura Limited	Functional powders for oral delivery
EP1474123A1 (en)	2002-01-03	2004-11-10	LEK Pharmaceuticals D.D.	Controlled release pharmaceutical formulation containing venlafaxine
US20030190355A1 (en) *	2002-04-05	2003-10-09	Hermelin Marc S.	Modified release minerals
EP1894562B1 (en) *	2002-08-15	2010-12-15	Euro-Celtique S.A.	Pharmaceutical compositions comprising an opioid antagonist
US6562378B1 (en) *	2002-08-16	2003-05-13	Tsar Health Private Ltd.	Nutritional supplement for adolescents
BRPI0414000B8 (pt) *	2003-08-29	2021-05-25	Lifecycle Pharma As	composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica

2005
- 2005-12-01 FR FR0512189A patent/FR2894143B1/fr not_active Expired - Lifetime
2006
- 2006-11-23 JP JP2008542790A patent/JP5674275B2/ja active Active
- 2006-11-23 CA CA2632547A patent/CA2632547C/fr active Active
- 2006-11-23 DK DK06831163.8T patent/DK1954251T3/da active
- 2006-11-23 BR BRPI0619774-4A patent/BRPI0619774B1/pt active IP Right Grant
- 2006-11-23 AT AT06831163T patent/ATE548030T1/de active
- 2006-11-23 EP EP06831163A patent/EP1954251B1/fr active Active
- 2006-11-23 RS RS20120229A patent/RS52308B/sr unknown
- 2006-11-23 RU RU2008126728/15A patent/RU2414211C2/ru active
- 2006-11-23 CN CNA2006800453522A patent/CN101321520A/zh active Pending
- 2006-11-23 PL PL06831163T patent/PL1954251T3/pl unknown
- 2006-11-23 ES ES06831163T patent/ES2383760T3/es active Active
- 2006-11-23 WO PCT/FR2006/002577 patent/WO2007063200A1/fr not_active Ceased
- 2006-11-23 PT PT06831163T patent/PT1954251E/pt unknown
- 2006-11-23 SI SI200631341T patent/SI1954251T1/sl unknown
- 2006-11-23 UA UAA200808585A patent/UA93530C2/ru unknown
- 2006-11-23 US US12/085,501 patent/US8834923B2/en active Active
- 2006-11-23 KR KR1020087008548A patent/KR101332744B1/ko active Active
- 2006-11-23 NZ NZ566783A patent/NZ566783A/en unknown
- 2006-11-23 AU AU2006319077A patent/AU2006319077B2/en active Active
- 2006-11-30 TW TW095144284A patent/TWI374035B/zh active
- 2006-12-01 AR ARP060105306A patent/AR057212A1/es not_active Application Discontinuation
2008
- 2008-02-28 ZA ZA200801896A patent/ZA200801896B/xx unknown
- 2008-03-07 MA MA30732A patent/MA29770B1/fr unknown
- 2008-04-02 TN TNP2008000152A patent/TNSN08152A1/fr unknown
- 2008-04-29 NO NO20082047A patent/NO339720B1/no unknown
- 2008-05-27 IL IL191758A patent/IL191758A/en active IP Right Grant

Also Published As

Publication number	Publication date
DK1954251T3 (da)	2012-07-02
NO20082047L (no)	2008-04-29
CN101321520A (zh)	2008-12-10
NZ566783A (en)	2010-12-24
AU2006319077A1 (en)	2007-06-07
IL191758A0 (en)	2008-12-29
CA2632547C (fr)	2014-03-25
KR20080044911A (ko)	2008-05-21
MA29770B1 (fr)	2008-09-01
TWI374035B (en)	2012-10-11
US8834923B2 (en)	2014-09-16
UA93530C2 (ru)	2011-02-25
EP1954251A1 (fr)	2008-08-13
RU2414211C2 (ru)	2011-03-20
US20090162429A1 (en)	2009-06-25
KR101332744B1 (ko)	2013-11-25
AR057212A1 (es)	2007-11-21
ZA200801896B (en)	2009-09-30
CA2632547A1 (fr)	2007-06-07
NO339720B1 (no)	2017-01-23
ATE548030T1 (de)	2012-03-15
BRPI0619774A2 (pt)	2011-10-18
TW200800303A (en)	2008-01-01
FR2894143A1 (fr)	2007-06-08
PT1954251E (pt)	2012-06-06
EP1954251B1 (fr)	2012-03-07
AU2006319077B2 (en)	2012-03-29
JP2009517445A (ja)	2009-04-30
FR2894143B1 (fr)	2008-05-02
JP5674275B2 (ja)	2015-02-25
RS52308B (sr)	2012-12-31
RU2008126728A (ru)	2010-01-10
SI1954251T1 (sl)	2012-08-31
WO2007063200A1 (fr)	2007-06-07
IL191758A (en)	2014-11-30
BRPI0619774B1 (pt)	2021-06-01
TNSN08152A1 (fr)	2009-10-30
ES2383760T3 (es)	2012-06-26

Publication	Publication Date	Title
ZA200902632B (en)	2010-07-28	Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
ZA200800781B (en)	2009-06-24	Powdered lime composition, method of preparing same and use thereof
TWI365866B (en)	2012-06-11	Amide derivatives, process for preparation thereof and use thereof as insecticide
ZA200801896B (en)	2009-09-30	Slow-release composition, method for the preparation thereof, and use of the same
EP2098222A4 (en)	2012-12-26	GRANULAR COMPOSITION CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCE AND METHOD FOR PRODUCING THE SAME
IL214183A (en)	2015-03-31	Pharma-informatics system and method, preparation for use with it and method for preparation of the preparation
ZA200705750B (en)	2008-11-26	Compositions and methods for stabilizing active pharmaceutical ingredients
IL195528A (en)	2014-07-31	Pyridazine compound, methods of preparation, a pharmaceutical composition containing it, its use and intermediate material
ZA200708304B (en)	2008-11-26	Dipeptidyl Peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
IL204079A (en)	2015-09-24	Pesticide exterminators and methods of increasing the effectiveness of active material exterminate pests
EP1832298A4 (en)	2012-12-12	MATRIX-TYPE-CONTROLLED RELEASE PREPARATION COMPRISING A BASIC SUBSTANCE OR SALT THEREOF AND PROCESS FOR PRODUCTION THEREOF
IL185034A0 (en)	2008-06-05	1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics
IL189914A0 (en)	2008-08-07	Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
IL184448A0 (en)	2007-10-31	Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use
ZA200706865B (en)	2008-09-25	Miocroporous crystalline material, zeolite ITQ-33, preparation method thereof and use of same
EP1874298A4 (en)	2009-08-05	METHOD AND COMPOSITIONS FOR THE PREPARATION, FORMULATION AND USE OF 1-ARYL-3-AZABICYCLO [3,1,0] HEXANES
IL176515A0 (en)	2006-10-05	1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
IL188032A0 (en)	2008-03-20	Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
IL185970A0 (en)	2008-01-06	Composition of spirulinas rich in active ingredients, method for obtaining it and its use
IL190459A0 (en)	2008-11-03	Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals
EP1916251A4 (en)	2010-09-08	ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ZA200900207B (en)	2009-12-30	Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
IL190861A0 (en)	2008-11-03	Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
ZA200606542B (en)	2008-07-30	1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
IL187419A0 (en)	2008-02-09	Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents